Lucid Diagnostics (LUCD) News Today $0.99 -0.02 (-1.99%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Lucid Diagnostics: Strong Growth Potential Justifies Buy RatingNovember 15 at 6:05 PM | markets.businessinsider.comLucid Diagnostics: Buy Rating Affirmed on Strong Revenue Growth and Future Expansion PotentialNovember 15 at 6:05 PM | markets.businessinsider.comLucid Diagnostics (NASDAQ:LUCD) Price Target Cut to $2.00 by Analysts at Cantor FitzgeraldCantor Fitzgerald decreased their target price on Lucid Diagnostics from $3.00 to $2.00 and set an "overweight" rating for the company in a report on Friday.November 15 at 10:33 AM | marketbeat.comLucid Diagnostics (NASDAQ:LUCD) Earns "Buy" Rating from Canaccord Genuity GroupCanaccord Genuity Group reaffirmed a "buy" rating and issued a $3.00 target price on shares of Lucid Diagnostics in a research report on Thursday.November 14 at 11:15 AM | marketbeat.comLucid Diagnostics Inc (LUCD) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amid ...November 14 at 9:54 AM | finance.yahoo.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2024 Earnings Call TranscriptNovember 14 at 9:54 AM | msn.comNeedham & Company LLC Reiterates Buy Rating for Lucid Diagnostics (NASDAQ:LUCD)Needham & Company LLC reiterated a "buy" rating and issued a $2.50 target price on shares of Lucid Diagnostics in a research note on Thursday.November 14 at 8:48 AM | marketbeat.comLucid Diagnostics Reports Revenue Growth and Secures FundingNovember 14 at 2:10 AM | markets.businessinsider.comOptimistic Outlook for Lucid Diagnostics: Buy Rating Amid Strong Q3 Performance and Future Growth PotentialNovember 14 at 2:10 AM | markets.businessinsider.comLucid Diagnostics Inc. (LUCD) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comLucid Diagnostics Provides Business Update and Third Quarter 2024 Financial ResultsNovember 13, 2024 | prnewswire.comA Glimpse of Lucid Diagnostics's Earnings PotentialNovember 13, 2024 | benzinga.comLucid Diagnostics (LUCD) Scheduled to Post Quarterly Earnings on WednesdayLucid Diagnostics (NASDAQ:LUCD) will be releasing earnings before the market opens on Wednesday, November 13, Zacks reports.November 9, 2024 | marketbeat.comLucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed PublicationNovember 7, 2024 | prnewswire.comLucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue DriversNovember 5, 2024 | prnewswire.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024October 30, 2024 | prnewswire.comLucid Diagnostics (NASDAQ:LUCD) Trading 1.5% Higher - Here's What HappenedLucid Diagnostics (NASDAQ:LUCD) Trading 1.5% Higher - Here's WhyOctober 30, 2024 | marketbeat.comLucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA TestOctober 15, 2024 | prnewswire.comLucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 9, 2024 | prnewswire.comLucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024October 8, 2024 | prnewswire.comOctober's 4 Best Penny Stocks: High-Risk, High-Reward Picks (LUCD)Penny stocks are a risky but potentially rewarding opportunity for investors willing to take on their uncertainty; these stocks may stand out from the pack.October 4, 2024 | marketbeat.comLucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL PlayersOctober 1, 2024 | finance.yahoo.comAmerican Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestSeptember 24, 2024 | prnewswire.comPAVmed Announces Efforts to Regain Compliance with Nasdaq Listing RequirementsSeptember 16, 2024 | prnewswire.comLucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressSeptember 10, 2024 | prnewswire.comLucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthSeptember 3, 2024 | prnewswire.comLucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerAugust 20, 2024 | prnewswire.comPAVmed Inc.: PAVmed Provides Business Update and Second Quarter 2024 Financial ResultsAugust 14, 2024 | finanznachrichten.deLucid Diagnostics Inc. (LUCD) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | seekingalpha.comLucid Diagnostics: Strong Buy Rating on Rising Test Volume and Promising Coverage ProspectsAugust 13, 2024 | markets.businessinsider.comThe American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerAugust 13, 2024 | prnewswire.comLucid Diagnostics Provides Business Update and Second Quarter 2024 Financial ResultsAugust 12, 2024 | finance.yahoo.comLucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing EventAugust 8, 2024 | prnewswire.comLucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer TestingAugust 6, 2024 | prnewswire.comLucid Diagnostics to Participate in Upcoming Investor ConferencesAugust 5, 2024 | prnewswire.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024July 29, 2024 | prnewswire.comLucid Diagnostics Announces Record Quarterly EsoGuard® Test VolumeJuly 23, 2024 | prnewswire.comLucid Diagnostics Launches New Corporate WebsiteJuly 11, 2024 | prnewswire.comLucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationJuly 2, 2024 | prnewswire.com4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer TestingJune 12, 2024 | prnewswire.comWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024May 20, 2024 | investorplace.comBuy Rating Affirmed for Lucid Diagnostics Amid Positive Financial and Clinical MilestonesMay 15, 2024 | markets.businessinsider.comQ1 2024 PAVmed Inc Earnings CallMay 15, 2024 | finance.yahoo.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2024 Earnings Call TranscriptMay 14, 2024 | insidermonkey.comLucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 14, 2024 | finance.yahoo.comPAVmed Provides Business Update and First Quarter 2024 Financial ResultsMay 13, 2024 | prnewswire.comAnalysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Jasper Therapeutics (JSPR) and Lucid Diagnostics (LUCD)May 13, 2024 | markets.businessinsider.comLUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024May 13, 2024 | investorplace.comLucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsMay 13, 2024 | finance.yahoo.comLucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsMay 7, 2024 | prnewswire.com Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address Strange: Why is Amazon suddenly yielding 39.70%? (Ad)Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%! Click here to see this breakthrough before everyone else → LUCD Media Mentions By Week LUCD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUCD News Sentiment▼0.390.56▲Average Medical News Sentiment LUCD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUCD Articles This Week▼181▲LUCD Articles Average Week Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BDSX News SGHT News SKIN News NPCE News PROF News NVRO News BWAY News PDEX News DRTS News LAKE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUCD) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LUCD Stock Alerts